356 related articles for article (PubMed ID: 9000700)
1. Systemic bias of cytokine production toward cell-mediated immune regulation in IDDM and toward humoral immunity in Graves' disease.
Kallmann BA; Hüther M; Tubes M; Feldkamp J; Bertrams J; Gries FA; Lampeter EF; Kolb H
Diabetes; 1997 Feb; 46(2):237-43. PubMed ID: 9000700
[TBL] [Abstract][Full Text] [Related]
2. Combined analysis of GAD65 and ICA512(IA-2) autoantibodies in organ and non-organ-specific autoimmune diseases confers high specificity for insulin-dependent diabetes mellitus.
Pietropaolo M; Peakman M; Pietropaolo SL; Zanone MM; Foley TP; Becker DJ; Trucco M
J Autoimmun; 1998 Feb; 11(1):1-10. PubMed ID: 9480718
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic islet cell cytoplasmic antibody in diabetes is represented by antibodies to islet cell antigen 512 and glutamic acid decarboxylase.
Myers MA; Rabin DU; Rowley MJ
Diabetes; 1995 Nov; 44(11):1290-5. PubMed ID: 7589826
[TBL] [Abstract][Full Text] [Related]
4. Early Th1 response in unprimed nonobese diabetic mice to the tyrosine phosphatase-like insulinoma-associated protein 2, an autoantigen in type 1 diabetes.
Trembleau S; Penna G; Gregori S; Magistrelli G; Isacchi A; Adorini L
J Immunol; 2000 Dec; 165(12):6748-55. PubMed ID: 11120794
[TBL] [Abstract][Full Text] [Related]
5. High T cell responses to the glutamic acid decarboxylase (GAD) isoform 67 reflect a hyperimmune state that precedes the onset of insulin-dependent diabetes.
Honeyman MC; Stone N; de Aizpurua H; Rowley MJ; Harrison LC
J Autoimmun; 1997 Apr; 10(2):165-73. PubMed ID: 9185878
[TBL] [Abstract][Full Text] [Related]
6. Cellular immune response to diverse islet cell antigens in IDDM.
Durinovic-Bellò I; Hummel M; Ziegler AG
Diabetes; 1996 Jun; 45(6):795-800. PubMed ID: 8635655
[TBL] [Abstract][Full Text] [Related]
7. Profound reduction in T-helper (Th) 1 lymphocytes in peripheral blood from patients with concurrent type 1 diabetes and Graves' disease.
Aso Y; Matsuura H; Momobayashi A; Inukai Y; Sugawara N; Nakano T; Yamamoto R; Wakabayashi S; Takebayashi K; Inukai T
Endocr J; 2006 Jun; 53(3):377-85. PubMed ID: 16717396
[TBL] [Abstract][Full Text] [Related]
8. Systemic levels of cytokines and GAD-specific autoantibodies isotypes in Chinese IDDM patients.
Ng WY; Thai AC; Lui KF; Yeo PP; Cheah JS
Diabetes Res Clin Pract; 1999 Feb; 43(2):127-35. PubMed ID: 10221665
[TBL] [Abstract][Full Text] [Related]
9. The relationship between humoral and cellular immunity to IA-2 in IDDM.
Ellis TM; Schatz DA; Ottendorfer EW; Lan MS; Wasserfall C; Salisbury PJ; She JX; Notkins AL; Maclaren NK; Atkinson MA
Diabetes; 1998 Apr; 47(4):566-9. PubMed ID: 9568688
[TBL] [Abstract][Full Text] [Related]
10. Schistosoma mansoni and alpha-galactosylceramide: prophylactic effect of Th1 Immune suppression in a mouse model of Graves' hyperthyroidism.
Nagayama Y; Watanabe K; Niwa M; McLachlan SM; Rapoport B
J Immunol; 2004 Aug; 173(3):2167-73. PubMed ID: 15265954
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in women.
Whittingham S; Byron SL; Tuomilehto J; Zimmet PZ; Myers MA; Vidgren G; Rowley MJ; Feeney SJ; Koskela P; Tuomilehto-Wolf E; Mackay IR
Diabet Med; 1997 Aug; 14(8):678-85. PubMed ID: 9272595
[TBL] [Abstract][Full Text] [Related]
12. Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto's thyroiditis (Th1) and Graves' disease (Th2).
Phenekos C; Vryonidou A; Gritzapis AD; Baxevanis CN; Goula M; Papamichail M
Neuroimmunomodulation; 2004; 11(4):209-13. PubMed ID: 15249726
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies to IA-2 in insulin-dependent diabetes mellitus. Measurements with a new immunoprecipitation assay.
Masuda M; Powell M; Chen S; Beer C; Fichna P; Rees Smith B; Furmaniak J
Clin Chim Acta; 2000 Jan; 291(1):53-66. PubMed ID: 10612717
[TBL] [Abstract][Full Text] [Related]
14. Cellular and molecular pathogenic mechanisms of insulin-dependent diabetes mellitus.
Yoon JW; Jun HS
Ann N Y Acad Sci; 2001 Apr; 928():200-11. PubMed ID: 11795511
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune diabetes: the role of T cells, MHC molecules and autoantigens.
Durinovic-Belló I
Autoimmunity; 1998; 27(3):159-77. PubMed ID: 9609134
[TBL] [Abstract][Full Text] [Related]
16. Production of interleukin (IL)-5 and IL-10 accompanies T helper cell type 1 (Th1) cytokine responses to a major thyroid self-antigen, thyroglobulin, in health and autoimmune thyroid disease.
Nielsen CH; Hegedüs L; Rieneck K; Moeller AC; Leslie RG; Bendtzen K
Clin Exp Immunol; 2007 Feb; 147(2):287-95. PubMed ID: 17223970
[TBL] [Abstract][Full Text] [Related]
17. Changes in Th1/Th2 cytokine balance in Graves' disease.
Kocjan T; Wraber B; Repnik U; Hojker S
Pflugers Arch; 2000; 440(5 Suppl):R94-5. PubMed ID: 11005626
[TBL] [Abstract][Full Text] [Related]
18. Islet-cell antigen-reactive T cells show different expansion rates and Th1/Th2 differentiation in type 1 diabetic patients and healthy controls.
Ott PA; Herzog BA; Quast S; Hofstetter HH; Boehm BO; Tary-Lehmann M; Durinovic-Bello I; Berner BR; Lehmann PV
Clin Immunol; 2005 Apr; 115(1):102-14. PubMed ID: 15870028
[TBL] [Abstract][Full Text] [Related]
19. Methimazole upregulates T-cell-derived cytokines without improving the existing Th1/Th2 imbalance in Graves' disease.
Kocjan T; Wraber B; Kocijancic A; Hojker S
J Endocrinol Invest; 2004 Apr; 27(4):302-7. PubMed ID: 15233546
[TBL] [Abstract][Full Text] [Related]
20. TSH receptor-adenovirus-induced Graves' hyperthyroidism is attenuated in both interferon-gamma and interleukin-4 knockout mice; implications for the Th1/Th2 paradigm.
Nagayama Y; Saitoh O; McLachlan SM; Rapoport B; Kano H; Kumazawa Y
Clin Exp Immunol; 2004 Dec; 138(3):417-22. PubMed ID: 15544617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
